Relay Therapeutics, Inc.
Relay Therapeutics, Inc. (RLAY) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 278 transactions totaling $257.8M, demonstrating a bearish sentiment with -$253.4M in net insider flow. The most recent transaction on Nov 3, 2025 involved a sale of 62,073 shares valued at $434.5K.
RLAY Insider Activity Summary
Who Is Buying RLAY Stock?
No significant insider buying has been recorded for RLAY in the recent period.
Who Is Selling RLAY Stock?
No significant insider selling has been recorded for RLAY in the recent period.
Is Relay Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RLAY is bearish with an Insider Alignment Score of 1/100 and a net flow of -$253.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
RLAY Frequently Asked Questions
Understanding RLAY Insider Activity
Insider trading at Relay Therapeutics, Inc. (RLAY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading RLAY stock, having executed 278 transactions in the past 90 days. The most active insider is Robert I. Tepper (Executive), who has made 12 transactions totaling $227.1M.
Related Tools
Track Relay Therapeutics, Inc. Insider Activity
Get notified when executives and directors at RLAY file new Form 4 transactions